Keywords:Heart diseaseHeart failure with preserved ejection fractionCardiac biomarker
Accepted
Rui Zhang 1, Yi Zhu2,3,4,5,6
1The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China
2Clinical and Technical Support, Philips Healthcare (Xi'an), Xi'an, China
3Department of Clinical & Technical Support, Clinical and Technical Support, Philips Healthcare (Xi'an), Xi'an, China
4Department of Clinical & Technical Support, Philips Healthcare (Beijing), Beijing, China
5Philips Healthcare (Beijing), Beijing, China
6Clinical and Technical Support, Philips Healthcare (Beijing), Beijing, China
Presenting Author: Rui Zhang
Synopsis
Motivation:
Goals:
Approach:
Results:
Full abstract & presentation
The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.
Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.
To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.
1. Campbell P, Rutten FH, Lee MM, Hawkins NM, Petrie MC. Heart failure with preserved ejection fraction: everything the clinician needs to know. Lancet. 2024 Mar 16;403(10431):1083-1092. doi: 10.1016/S0140-6736(23)02756-3. Epub 2024 Feb 14. Erratum in: Lancet. 2024 Mar 16;403(10431):1026. doi: 10.1016/S0140-6736(24)00494-X. PMID: 38367642. [doi][pmid]
2. 4.Santaguida P L, Don-Wauchope A C, Oremus M, et al. BNP and NT-proBNP as prognostic markers in persons with acute decompensated heart failure: a systematic review[J]. Heart failure reviews, 2014, 19: 453-470.
3. 10.Kim P K, Hong Y J, Im D J, et al. Myocardial T1 and T2 mapping: techniques and clinical applications[J]. Korean journal of radiology, 2017, 18(1): 113-131.